Back to Trades
Robinson Chandler
Chief Executive OfficerDirectorCIK 0001727334
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Robinson Chandler, Chief Executive Officer, Director, accounts for 7 disclosed filings worth $2.8M, all concentrated in Monopar Therapeutics (MNPR), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $672.0K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $378.1K |
| Apr 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $108.0K |
| Jan 30 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Other | $0 |
| Jan 5 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $167.0K |
| Dec 8 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Award | $1.3M |
| Oct 2 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Exercise | $216.1K |
| Jul 16 | MNPR Monopar Therapeutics | Robinson Chandler | Chief Executive Officer, Director | Sell | $672.0K |
7 filings